Security Snapshot

Savara Inc - Common Stock, par value $0.001 per share (the "Shares") (SVRA) Institutional Ownership

CUSIP: 805111101

13F Institutional Holders and Ownership History from Q1 2016 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

178

Shares (Excl. Options)

216,926,914

Price

$6.16

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+4,501,764
Value change
+$28,896,912
Number of holders
178
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
220,588,235
SEC-reported price per share
$5.81
Insider filing price
$5.81
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • SVRA - Savara Inc - Common Stock, par value $0.001 per share (the "Shares") is tracked under CUSIP 805111101.
  • 178 institutions reported positions in Q2 2026.
  • 12 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 185 to 178 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $1,158,876,914 to $1,336,149,265.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 178 institutions filings for Q2 2026.

Open SEC evidence

Security key

805111101

Latest holder period

Q2 2026

13F holders

178

13D/G owners

12

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
12
Security
SVRA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Growth Equity Opportunities 17, LLC 12% $87,362,412 24,471,264 Growth Equity Opportunities 17, LLC 12 Nov 2025
Venrock Healthcare Capital Partners III, L.P. 9.9% +37% $123,617,225 +$48,545,450 20,881,288 +65% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
Bain Capital Life Sciences Fund II, L.P. 10% $55,969,975 17,600,621 Bain Capital Life Sciences Fund II, L.P. 25 Mar 2025
FARALLON CAPITAL MANAGEMENT, L.L.C. 6.8% $94,350,000 15,000,000 Farallon Capital Management, L.L.C. 30 Jun 2026
Farallon Capital Partners, L.P. 6.9% -31% $90,445,500 -$19,831,599 15,000,000 -18% Dapice Joshua J. 31 Dec 2025
Flynn James E 6.7% $48,441,330 13,569,000 Deerfield Mgmt, L.P. 30 Oct 2025
TCG Crossover GP I, LLC 6.1% $73,184,254 12,362,205 TCG Crossover GP I, LLC 31 Dec 2025
BlackRock, Inc. 5.4% +12% $66,069,364 +$15,933,163 10,957,322 +32% BlackRock, Inc. 31 Dec 2025
Frazier Life Sciences Public Fund, L.P. 4.1% +5% $49,390,844 +$9,458,692 8,343,048 +24% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
Nantahala Capital Management, LLC 3.6% -29% $43,481,115 -$8,469,105 7,344,783 -16% Nantahala Capital Management, LLC 31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP 3.2% $17,431,660 5,481,654 Wellington Management Group LLP 31 Dec 2024
Vestal Point Capital, LP 2.3% -67% $14,333,550 -$24,133,200 4,015,000 -63% Vestal Point Capital, LP 30 Sep 2025

As of 30 Jun 2026, 178 institutional investors reported holding 216,926,914 shares of Savara Inc - Common Stock, par value $0.001 per share (the "Shares") (SVRA). This represents 98% of the company’s total 220,588,235 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
84%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
NEA Management Company, LLC 11% 24,471,264 0% 9.5% $150,742,986
Bain Capital Life Sciences Investors, LLC 8% 17,600,621 0% 6.4% $108,419,826
Venrock Adviser, LLC 6.7% 14,745,943 +7.3% 2.8% $90,835,009
DEERFIELD MANAGEMENT COMPANY, L.P. 6.2% 13,569,000 0% 0.87% $83,585,040
BlackRock, Inc. 5.7% 12,494,498 +11% 0% $76,966,107
TCG Crossover Management, LLC 5.6% 12,362,205 0% 1.8% $76,151,183
Frazier Life Sciences Management, L.P. 4.4% 9,720,852 0% 1.3% $59,880,448
Polar Capital Holdings Plc 4.3% 9,541,786 0% 0.17% $58,777,402
VANGUARD CAPITAL MANAGEMENT LLC 3.6% 7,932,545 +1.9% 0% $48,864,477
Nantahala Capital Management, LLC 3.2% 6,976,810 -5% 2.6% $42,977,150
STATE STREET CORP 3% 6,553,348 -2.3% 0% $40,368,624
MARSHALL WACE, LLP 2.8% 6,256,989 +39% 0.03% $38,543,053
RTW INVESTMENTS, LP 2.7% 5,952,380 0% 0.31% $36,666,661
Woodline Partners LP 1.9% 4,245,119 0% 0.08% $26,149,933
ORBIMED ADVISORS LLC 1.8% 3,959,900 +524% 0.46% $24,392,984
GEODE CAPITAL MANAGEMENT, LLC 1.8% 3,872,133 +7.7% 0% $23,857,705
Spruce Street Capital LP 1.6% 3,452,576 +2.1% 4.2% $21,267,868
Rosalind Advisors, Inc. 1.4% 3,178,121 -0.8% 7.4% $19,577,225
EMERALD ADVISERS, LLC 1.4% 3,148,439 -6.6% 0.46% $19,394,384
Pictet Asset Management Holding SA 1.3% 2,763,055 +21% 0.02% $17,020,419
Vestal Point Capital, LP 1.2% 2,720,000 +4.6% 0.39% $16,755,200
WELLINGTON MANAGEMENT GROUP LLP 1.2% 2,694,812 -0.59% 0% $16,600,042
D. E. Shaw & Co., Inc. 1.1% 2,514,998 +19% 0.01% $15,492,388
Affinity Asset Advisors, LLC 1.1% 2,512,153 0% 0.76% $15,474,862
EMERALD MUTUAL FUND ADVISERS TRUST 1.1% 2,375,999 +0.31% 0.51% $14,636,154

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
39
Latest
Q2 2026
Rows shown
1-25 of 39
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 216,926,914 $1,336,149,265 +$28,896,912 $6.16 178
2026 Q1 212,258,088 $1,158,876,914 +$54,962,657 $5.46 185
2025 Q4 201,186,328 $1,213,175,994 +$226,717,931 $6.03 148
2025 Q3 163,027,204 $581,865,188 -$17,744,664 $3.57 124
2025 Q2 167,625,869 $382,185,936 +$4,604,999 $2.28 121
2025 Q1 165,084,968 $457,300,361 +$4,913,528 $2.77 133
2024 Q4 162,865,251 $500,000,306 -$4,524,160 $3.07 134
2024 Q3 160,489,937 $680,419,874 +$47,632,176 $4.24 124
2024 Q2 148,167,816 $597,127,886 +$107,030,245 $4.03 130
2024 Q1 121,071,712 $602,921,495 +$11,975,850 $4.98 119
2023 Q4 118,973,088 $559,183,072 +$9,052,732 $4.70 97
2023 Q3 116,727,664 $441,241,214 +$105,054,525 $3.78 83
2023 Q2 89,090,177 $284,756,437 +$19,803,798 $3.20 76
2023 Q1 83,504,156 $162,832,384 +$6,962,703 $1.95 67
2022 Q4 79,984,853 $123,981,605 +$92,945 $1.55 52
2022 Q3 79,924,185 $123,886,636 +$4,248,900 $1.55 47
2022 Q2 77,190,826 $117,329,451 +$2,431,393 $1.52 47
2022 Q1 75,835,578 $99,344,996 +$1,530,761 $1.31 45
2021 Q4 74,670,485 $92,591,002 -$976,827 $1.24 45
2021 Q3 75,014,959 $103,530,069 -$1,889,497 $1.38 54
2021 Q2 76,209,813 $129,561,285 +$1,307,097 $1.70 69
2021 Q1 75,191,392 $156,437,847 +$111,831,290 $2.08 77
2020 Q4 21,657,964 $24,908,582 -$596,543 $1.15 61
2020 Q3 17,084,936 $18,623,392 -$4,005,800 $1.09 62
2020 Q2 19,585,868 $48,753,921 +$1,741,034 $2.49 68
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .